IR-contact

Karl Hård, Head of Investor Relations & Business Development

Email: [email protected]
Phone: +46 733 011 944

Nicklas Westerholm, CEO

Email: [email protected]
Phone: +46 733 542 062

Yilmaz Mahshid, CFO

Email: [email protected]
Phone: +46 722 316 800

News & Insights

News & Insights This section provides updates on Egetis Therapeutics, including regulatory announcements, corporate news, media coverage and perspectives related to rare diseases and scientific developments. Content is…

Explore